AI assistant
UCB — Major Shareholding Notification 2017
Feb 1, 2017
4017_mrq_2017-02-01_4ebef789-ffbf-4501-a829-2493f5bb1765.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Brussels (Belgium), 1 February 2017 – 20:00 (CET) – regulated information
1. Summary of the notifications
Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received 2 transparency notifications dated 27 and 30 January 2017 respectively, from BlackRock, Inc. (having its registered offices at 55 East 52nd Street, New York, NY, 10055, U.S.A.).
In the first notification, BlackRock, Inc. has notified that, following an acquisition of UCB shares with voting rights by its affiliates, its shareholding in UCB SA/NV had increased and had crossed the 3% threshold on 26 January 2017. In the second notification, BlackRock, Inc. has informed that, following a disposal of UCB shares with voting rights by its affiliates, its shareholding in UCB SA/NV has decreased and has crossed downward the 3% threshold on 27 January 2017.
On 26 January 2017, BlackRock, Inc. (taking into account the holding of its affiliates) owned 5 858 144 UCB shares with voting rights (versus 5 783 437 UCB shares in its previous notification dated 19 January 2017), representing 3.01% of the total number of shares issued by the company (194 505 658) (versus 2.97% in the notification dated 19 January 2017).
On 27 January 2017, BlackRock, Inc. (taking into account the holding of its affiliates) owned 5 744 828 UCB shares with voting rights, representing 2.95% of the total number of shares issued by the company.
2. Content of the notifications
The transparency notification dated 27 January 2017 includes the following information:
- Date on which the threshold is crossed: 26 January 2017.
- Notified details:
| A) Voting rights | Previous notification | After the transaction | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| # of voting rights | # of voting rights | % of voting rights | ||||||||
| Holders of voting rights | Linked to securities | Not linked to the securities |
Linked to securities |
Not linked to the securities |
||||||
| BlackRock, Inc. | 0 | 0 | 0,00% | |||||||
| BlackRock (Netherlands) B.V. | 19.816 | 19.816 | 0,01% | |||||||
| BlackRock (Singapore) Limited | 6.386 | 6.386 | 0,00% | |||||||
| BlackRock Advisors (UK) Limited | 711.451 | 802.129 | 0,41% | |||||||
| BlackRock Advisors, LLC | 63.214 | 63.576 | 0,03% | |||||||
| BlackRock Asset Management Canada Limited |
61.391 | 61.391 | 0,03% | |||||||
| BlackRock Asset Management Deutschland AG |
231.265 | 231.265 | 0,12% | |||||||
| BlackRock Asset Management North Asia Limited |
644 | 644 | 0,00% | |||||||
| BlackRock Financial Management, Inc. |
81.547 | 81.575 | 0,04% | |||||||
| BlackRock Fund Advisors | 1.781.510 | 1.789.805 | 0,92% | |||||||
| BlackRock Institutional Trust Company, National Association |
2.035.122 | 2.034.555 | 1,05% | |||||||
| BlackRock International Limited | 11.927 | 11.609 | 0,01% | |||||||
| BlackRock Investment Management (Australia) Limited |
41.852 | 41.852 | 0,02% | |||||||
| BlackRock Investment Management (UK) Limited |
311.955 | 313.823 | 0,16% | |||||||
| BlackRock Investment Management, LLC |
234.845 | 230.604 | 0,12% | |||||||
| BlackRock Japan Co., Ltd. | 190.512 | 169.114 | 0,09% | |||||||
| Subtotal | 5.783.437 | 5.858.144 | 3,01% | |||||||
| TOTAL | 5.858.144 0 |
3,01% | 0,00% | |||||||
| B) Equivalent financial instruments | After the transaction | |||||||||
| Holders of equivalent financial instruments |
Type of financial instrument | Expiration date Exercise period or date |
# of voting rights that may be acquired if the instrument is exercised |
% of voting rights | Settlement | |||||
| BlackRock Advisors (UK) Limited | Securities Lent | 105.350 | 0,05% | physical | ||||||
| BlackRock Fund Advisors Securities Lent |
1.118 | 0,00% | physical | |||||||
| BlackRock Institutional Trust Company, National Association |
Securities Lent | 9.606 | 0,00% | physical | ||||||
| BlackRock Japan Co., Ltd. | Securities Lent | 24.614 | 0,01% | physical | ||||||
| BlackRock Institutional Trust Company, National Association |
Contract for Difference | 7.683 | 0,00% | cash |
BlackRock International Limited Contract for Difference 239 0,00% cash
(UK) Limited Contract for Difference 8.898 0,00% cash
TOTAL 157.508 0,08%
BlackRock Investment Management
| TOTAL (A & B) | # of voting rights % of voting rights | |||
|---|---|---|---|---|
| CALCULATE | 6.015.652 | 3,09% |
• Additional information:
The disclosure obligation arose due to voting rights for BlackRock, Inc. going above 3%.
The transparency notification dated 30 January 2017 includes the following information:
- Date on which the threshold is crossed: 27 January 2017.
- Notified details:
UCB
News
| A) Voting rights Previous notification |
After the transaction | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| # of voting rights | # of voting rights | % of voting rights | ||||||||
| Holders of voting rights | Linked to securities | Not linked to the securities |
Linked to securities |
Not linked to the securities |
||||||
| BlackRock, Inc. | $\mathbf 0$ | $\mathbf 0$ | 0,00% | |||||||
| BlackRock (Netherlands) B.V. | 19.816 | 19.816 | 0,01% | |||||||
| BlackRock (Singapore) Limited | 6.386 | 6.386 | 0,00% | |||||||
| BlackRock Advisors (UK) Limited | 802.129 | 836.658 | 0,43% | |||||||
| BlackRock Advisors, LLC | 63.576 | 63.253 | 0,03% | |||||||
| BlackRock Asset Management Canada Limited |
61.391 | 61.391 | 0,03% | |||||||
| BlackRock Asset Management Deutschland AG |
231.265 | 230.309 | 0,12% | |||||||
| BlackRock Asset Management North Asia Limited |
644 | 644 | 0,00% | |||||||
| BlackRock Financial Management, Inc. |
81.575 | 78.888 | 0,04% | |||||||
| BlackRock Fund Advisors | 1.789.805 | 1.791.052 | 0,92% | |||||||
| BlackRock Institutional Trust Company, National Association |
2.034.555 | 2.034.402 | 1,05% | |||||||
| BlackRock International Limited | 11.609 | 11.609 | 0,01% | |||||||
| BlackRock Investment Management (Australia) Limited |
41.852 | 41.852 | 0,02% | |||||||
| BlackRock Investment Management (UK) Limited |
313.823 | 158.913 | 0,08% | |||||||
| BlackRock Investment Management, LLC |
230.604 | 230.604 | 0,12% | |||||||
| BlackRock Japan Co., Ltd. | 169.114 | 179.051 | 0,09% | |||||||
| Subtotal | 5.858.144 | 5.744.828 | 2,95% | |||||||
| TOTAL | 5.744.828 | $\bf{0}$ | 2,95% | 0,00% | ||||||
| B) Equivalent financial instruments | After the transaction | |||||||||
| Holders of equivalent financial instruments |
Type of financial instrument | Expiration date | Exercise period or date |
# of voting rights that may be acquired if the instrument is exercised |
% of voting rights | Settlement | ||||
| BlackRock Advisors (UK) Limited | Securities Lent | 85.831 | 0,04% | physical | ||||||
| BlackRock Fund Advisors | Securities Lent | 1.118 | 0,00% | physical | ||||||
| BlackRock Institutional Trust Company, National Association |
Securities Lent | 9.606 | 0,00% | physical | ||||||
| BlackRock Institutional Trust Company, National Association |
Contract for Difference | 7.683 | 0,00% | cash | ||||||
| BlackRock Investment Management (UK) Limited |
Contract for Difference | 6.170 | 0,00% | cash | ||||||
| BlackRock Japan Co., Ltd. | Securities Lent | 14.677 | 0,01% | physical | ||||||
| IUIAL | 125.085 | U.Ub% | |
|---|---|---|---|
| TOTAL (A & B) | # of voting rights % of voting rights | ||
| CALCULATE | 5.869.913 | 3,02% |
Inspired by patients.
Driven by science.
• Additional information:
The disclosure obligation arose due to voting rights for BlackRock, Inc. going below 3%.
The information mentioned hereafter was identical in both notifications:
- Reason for the notification: Acquisition or disposal of voting securities or voting rights.
- Notification by: A parent undertaking or a controlling person.
- Persons subject to the notification requirement:
| Name | Address (for legal entities) |
|---|---|
| BlackRock, Inc. | 55 East 52nd Street, New York, NY, 10055, U.S.A. |
| BlackRock (Netherlands) B.V. | Rembrandt Tower, 17th floor, Amstelplein, Amsterdam, Netherlands |
| BlackRock (Singapore) Limited | 20 Anson Road #18-01, Singapore, 79912, Singapore |
| BlackRock Advisors (UK) Limited | 12 Throgmorton Avenue, London, EC2N 2DL, U.K. |
| BlackRock Advisors, LLC | 100 Bellevue Parkway, Wilmington, DE, 19809, U.S.A. |
| BlackRock Asset Management Canada Limited | 161 Bay Street, Suite 2500, Toronto, Ontario, M5J 2S1, Canada |
| BlackRock Asset Management Deutschland AG | Max-Joseph-Straße 6, Munich, 80333, Germany |
| BlackRock Asset Management North Asia Limited | 15/F, 16/F, 17/F Citibank Tower & 17/F ICBC Tower, 3 Garden Road, Central, Hong Kong |
| BlackRock Financial Management, Inc. | 55 East 52nd Street, New York, NY, 10055, U.S.A. |
| BlackRock Fund Advisors | 400 Howard Street, San Francisco, CA, 94105, U.S.A. |
| BlackRock Institutional Trust Company, National Association |
400 Howard Street, San Francisco, CA, 94105, U.S.A. |
| BlackRock International Limited | Exchange Place One, 1 Semple Street, Edinburgh, EH3 8BL, U.K. |
| BlackRock Investment Management (Australia) Limited |
Level 37, Chifley Tower, 2 Chifley Square, Sydney NSW 2000 Australia |
| BlackRock Investment Management (UK) Limited | 12 Throgmorton Avenue, London, EC2N 2DL, U.K. |
| BlackRock Investment Management, LLC | 1 University Square Drive, Princeton, NJ, 8540, U.S.A. |
| BlackRock Japan Co., Ltd. | 1-8-3 Marunouchi Chiyoda-ku, Trust Tower Main, Tokyo, 100-8217, Japan |
• Threshold crossed (in %): 3%.
- Denominator: 194 505 658.
- Chain of controlled undertakings through which the holding is effectively held:
Please see the full chain of control in the PDF which is attached to the notifications.
3. Further information
This press release and the detailed transparency notifications are available on UCB SA/NV's website via the following link.
An updated overview of the UCB SA/NV large shareholdings will be included in the corporate governance charter of UCB SA/NV, which is available on its website via the following link.
Investor Relations
Antje Witte, Investor Relations, UCB T +32 2 559 94 14, [email protected]
Isabelle Ghellynck, Investor Relations, UCB T +32 2 559 95 88, [email protected]
About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 7 500 people in approximately 40 countries, the company generated revenue of € 3.9 billion in 2015. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news